Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN351214 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN351214, RRID:AB_10805654
- Product name
- anti-Transient Receptor Potential Cation Channel, Subfamily M, Member 6 (TRPM6) (Cytoplasmic Domain) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide from cytoplasmic domain of mouse TRPM6 (region 1300-1400) conjugated to an immunogenic carrier protein was used as the antigen.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Cytoplasmic Domain
- Isotype
- IgG
- Vial size
- 500 μg
- Storage
- Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability.
- Handling
- Avoid freeze and thaw cycles.
Submitted references The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels.
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B
Nature 2004 Aug 12;430(7001):748-54
Nature 2004 Aug 12;430(7001):748-54
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.
Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP, Rieber EP
The Prostate 2003 Sep 1;56(4):270-9
The Prostate 2003 Sep 1;56(4):270-9
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
Tsavaler L, Shapero MH, Morkowski S, Laus R
Cancer research 2001 May 1;61(9):3760-9
Cancer research 2001 May 1;61(9):3760-9
No comments: Submit comment
No validations: Submit validation data